New Drug for TB Could Cut Treatment Time

Government Will Regulate Sale of Anti-TB Drugs
  • Indian scientists may have found a game-changing discovery that will shorten treatment for tuberculosis to four months from the standard six-month regimen of medication
  • Trials included an antibiotic prescribed for infections like pneumonia have revealed.
  • Through the seven-year clinical trials, scientists at the National Institute for Research in Tuberculosis have found that including moxifloxacin, a potent antibiotic, in a four-month regimen proved to be better than the standard six-month treatment.
  • The recurrence levels were almost the same in both the regimens but patients testing negative for potential to spread TB to others was higher with the new regimen.
  • The results, which were shared at the recent Union World Conference on Lung¬†health¬†at Barcelona,
  • Scientists say shortening treatment duration is important.